DJIA 15,914.74 -99.64 -0.62%
NASDAQ 4,283.59 14.83 0.35%
S&P 500 1,851.86 -0.35 -0.02%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

4.66 0.04 (0.87%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVAX $4.66 0.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.72
Previous Close $4.62
Daily Range $4.62 - $5.01
52-Week Range $4.08 - $15.01
Market Cap $1.3B
P/E Ratio -10.50
Dividend (Yield) $0.00 (0.0%)
Volume 8,146,167
Average Daily Volume 9,035,861
Current FY EPS -$0.44

Sector

Healthcare

Industry

Drug Makers

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary

Why Share of Novavax Inc Dropped 34% in January

Novavax's shares couldn't sidestep the month's biotech beatdown.

How The Pieces Add Up: IYH Targets $175

Insider Trading Alert - PII, NVAX And NOG Traded By Insiders

Trade-Ideas: Novavax (NVAX) Is Today's "Dead Cat Bounce" Stock

Novavax Prices $300M of Convertible Senior Notes Due 2023

Trade-Ideas: Novavax (NVAX) Is Today's "Perilous Reversal" Stock

10 Stocks Moving In Monday's Pre-Market Session

10 Stocks Moving In Wednesday's Pre-Market Session

3 Biotech Stocks With Jaw-Dropping Growth Potential in 2016

The Street is extremely bullish on Celldex Therapeutics, Inovio Pharmaceuticals, and Novavax in 2016. Here's a deeper look at why.

Stock To Watch: Novavax (NVAX) In Perilous Reversal

See More NVAX News...

NVAX's Top Competitors

NVAX $4.66 (0.87%)
Current stock: NVAX
AMGN $144.81 (1.15%)
Current stock: AMGN
GILD $87.77 (0.60%)
Current stock: GILD
BIIB $252.20 (0.88%)
Current stock: BIIB